Recall antigen delayed-type hypersensitivity skin testing in melanoma and acute leukemia patients and their associates.
Dexter L. Morris,Evan M. Hersh,Bartholomew P. Hsi,Jordan U. Gutterman,M. Marshall,G. Mavligit
IF: 11.2
Cancer Research
Abstract:mune response. It has been demonstrated to correlate with stage of disease (1, 6, 16, 31) and prognosis (2, 3, 14, 20) in many types of cancer. By various mechanisms, including surgery (17, 18), radiotherapy (8, 23), chemotherapy (23), and immunotherapy (11, 15, 32, 33), the human immune response can be altered.These changes can be docu mented with DTH skin tests, and thus this test of immuno logical competence has become an important tool in the management of cancer patients and the evaluation of treat ment (12). DTH skin test responses reflect a complex series of vascular, cellular, and mediator-associated effects (4). Age (9, 29), genetics (7), and environment (previous expo sure to the antigen) are known to have a significant effect on immune response. These factors are rarely considered in selecting appropriate control groups in immunological studies of cancer patients on, for that matter, patients with other diseases. They are of increasing importance when dealing with recall antigens as used in this study and many others. An opportunity to study the possible effects of some of these factors on DTH skin test reactivity occurred during a ABSTRACT Patients with malignant melanoma and acute leukemia and their relatives and other associates were screened as potential transfer factor donors and recipients with a battery of four recall, delayed-type hypersensitivity skin test anti gens. The skin test results of 336 associates and 179 patients were compared by a variety of techniques, includ ing converting the response in mm to a response score of 0 to 3. There was considerable variation in the response of the associates, 5% being anergic. There was a significant age variation in response to denmatophytin, streptokinase streptodonnase, and Candida (both increases and de creases with age) while purified protein derivative showed no such variation. Taking age into account, the response of Stage IV melanoma patients and acute leukemia patients was lower than that of the normal subjects, while the Stage III melanoma patients had slightly greaten responses than did the normals. The antigens most useful in differentiating between groups were Candida and dermatophytin , as well as an overall index of response which reflected the level of response to all the antigens. In a matched comparison of patients and their spouses, the same trends were evident. Comparison of melanoma patients' siblings to other asso ciate groups identified the siblings as low responders. This difference was highly significant for the index of overall response. This was not seen in siblings of leukemia pa tients. The importance of a well-matched control group of normal subjects for immunological studies of delayed-type hypersensitivity in cancer patients is discussed. Utilization of nonage- and nonenvironment-matched controls is to be discouraged.